Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,052 | -10,782 | -8,797 | -7,435 | -4,560 |
| Depreciation Amortization | 367 | 425 | 497 | 585 | 580 |
| Other Working Capital | -150 | 501 | 178 | -303 | 11 |
| Other Operating Activity | -1,006 | 702 | 1,537 | 1,184 | 587 |
| Operating Cash Flow | $-8,841 | $-9,155 | $-6,585 | $-5,970 | $-3,382 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -148 | -98 | -118 | -2 |
| Net Acquisitions | N/A | N/A | N/A | 906 | N/A |
| Other Investing Activity | 0 | 2,000 | -2,000 | 500 | 0 |
| Investing Cash Flow | $-30 | $1,852 | $-2,098 | $1,287 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,618 | N/A | N/A | N/A | 3,171 |
| Debt Repayment | -619 | -2 | -2 | -678 | -193 |
| Common Stock Issued | 12,396 | 4,975 | 7,927 | 10,165 | N/A |
| Other Financing Activity | -520 | 71 | -71 | 28 | 99 |
| Financing Cash Flow | $15,874 | $5,043 | $7,854 | $9,515 | $3,078 |
| Beginning Cash Position | 2,418 | 4,678 | 5,506 | 674 | 980 |
| End Cash Position | 9,423 | 2,418 | 4,678 | 5,506 | 674 |
| Net Cash Flow | $7,004 | $-2,259 | $-828 | $4,832 | $-306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,841 | -9,155 | -6,585 | -5,970 | -3,382 |
| Capital Expenditure | -30 | -148 | -98 | -118 | -2 |
| Free Cash Flow | -8,870 | -9,302 | -6,683 | -6,089 | -3,384 |